ImmunityBio
IBRX
$7.35
Share price
43.84%
Change (1 day)
162.50%
Change (1 year)
Categories
ImmunityBio (IBRX) - Net assets
Net assets on the balance sheet as of December 2023 : -$0.59 B
According to ImmunityBio's latest financial reports the company has -$0.59 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
ImmunityBio - Net assets on balance sheet (from 2020 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $-0.45 B | 84.42% |
| 2021-12-31 | $-0.25 B | 105.85% |
| 2020-12-31 | $-0.12 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.22 B | -138.24% | 🇺🇸 USA |